Which enzyme that participates in ketoacid metabolism is not present in the liver? a) HMG-CoA synthase...

Question

Question

Which enzyme that participates in ketoacid metabolism is not present in the liver?

a) HMG-CoA synthase

b)β-ketoacyl CoA transferase

c)Thiolase

d) β -hydroxybutyrate dehydrogenase

science biology

Answer 1

Answer #1

Answer 2

Similar Homework Help Questions

1. The key regulatory enzyme of cholesterol synthesis is A. HMG CoA synthase B. HMG CoA...

1. The key regulatory enzyme of cholesterol synthesis is A. HMG CoA synthase B. HMG CoA lyase C. HMG CoA reductase D. Mevalonate kinase
QUESTION 4 The rate limiting enzyme for cholesterol synthesis is A Acyl-CoA-cholesterol acyl transferase (ACAT) B....

QUESTION 4 The rate limiting enzyme for cholesterol synthesis is A Acyl-CoA-cholesterol acyl transferase (ACAT) B. HMG-CoA Lyase C. HMG-CoA Reductase D. HMG-CoA Synthase
Partial Question 6 1.5/3 pts What are all the reasons why ketone bodies are produced in...

Partial Question 6 1.5/3 pts What are all the reasons why ketone bodies are produced in the body? To regenerate COA To increase gluconeogenesis So the liver can burn fats safely Rectangul For energy for the brain and other tissues Incorrect Question 9 0/1 pts Which is the first enzyme required for ketone body formation? O HMG-CoA lyase O HMG-CoA synthase O Pyruvate dehydrogenase O Thiolase

In fatty acid metabolism, one of the metabolic order defects is MCAD (medium-chain acyl- CoA dehydrogenase)...

In fatty acid metabolism, one of the metabolic order defects is MCAD (medium-chain acyl- CoA dehydrogenase) deficiency, an autosomal recessive disorder, where vomiting and lethargy are triggered when an affected individual does not eat for an extended period of time. A different, rarer, disorder is MCAT (medium-chain ketoacyl-CoA thiolase) deficiency, which presents in similarly to MCAD, though has rarely been reported. Why do you think these two disorders are rare, and what would the difference in metabolites be (i.e. which...
Give the process/pathway where each of the following enzymes is involved: a. HMG CoA lyase b....

Give the process/pathway where each of the following enzymes is involved: a. HMG CoA lyase b. HMG CoA reductase c. Acetyl CoA carboxylase d. Acyl CoA dehydrogenase
40.Fatty acid synthase is an enzyme in the lipid metabolism pathway, that: A. occurs in the...

40.Fatty acid synthase is an enzyme in the lipid metabolism pathway, that: A. occurs in the mitochondrion in animal cells, 2 nor Section A B. utilises NADH as an electron donor C) requires NADPH as a substrate. D. requires acetic acid as a substrate. E. consists of a single multifunctional protein in plants and bacteria. 41.One round of beta oxidation produces 1 molecule of acetyl-CoA from a saturated Acyl-CoA molecule. Which reducing equivalents are made in this process in which...

Cholesterol biosynthesis involves a stepwise increase of carbon numbers from acetyl-CoA (C2) to ______ (C5), and,...

Cholesterol biosynthesis involves a stepwise increase of carbon numbers from acetyl-CoA (C2) to ______ (C5), and, finally, to squalene (C30). But, the rate-limiting step is catalyzed by _____. Inhibition of this enzyme is adopted as a strategy for the therapeutic control of cholesterol levels. Select one: a. isoprenoid ;;; HMG CoA synthase b. isoprenoid ;;; HMG CoA reductase c. flavonoid ;;; HMG CoA synthase d. flavonoid ;;; HMG CoA reductase e. None of these
In the liver, which of the following enzymes is inhibited by malonyl CoA? A: fatty acid...

In the liver, which of the following enzymes is inhibited by malonyl CoA? A: fatty acid synthase, B: Acetyl CoA carboxylase, C: CPT-1, D: Hormone sensitive lipase
HMG-CoA reductase, a critical enzyme in cholesterol synthesis is the target or statin inhibitors. You are characterizin...

HMG-CoA reductase, a critical enzyme in cholesterol synthesis is the target or statin inhibitors. You are characterizing a possible new inhibitor and want to determine its mode of binding to HMG-CoA reductase. Equilibrium dialysis measurements at 25°C, 30°C, and 37°C yielded dissociation constants (Ks) of 2.5 x 10* M, 1.5 x 10*, and 1.0 x 10* M, respectively, for the HMG- CoA reductase-inhibitor complex a. Is the binding becoming better or worse with increasing temperature? Explain. b. Using Excel or...

HMG-CoA reductase, a critical enzyme in cholesterol synthesis is the target or statin inhibitors. You are characteri...

HMG-CoA reductase, a critical enzyme in cholesterol synthesis is the target or statin inhibitors. You are characterizing a possible new inhibitor and want to determine its mode of binding to HMG-CoA reductase. Equilibrium dialysis measurements at 25 C, 30°C, and 37 C yielded dissociation constants (K.) of 2.5 x 10" М, 1.5 x 10", and 1.0 x 103 M, respectively, for the HMG-CoA reductase-inhibitor complex. a. Is the binding becoming better or worse with increasing temperature? Explain. b. Using Excel...